New
Hindi Medium: (Delhi) - GS Foundation (P+M) : 6th July 2026, 6:00 PM Hindi Medium: (Prayagraj) - GS Foundation (P+M) : 5th July 2026, 8:00 AM English Medium: (Delhi) - GS Foundation (P+M) : 26th July 2026 English Medium: (Prayagraj) - GS Foundation (P+M) : 15th July 2026, 8:00 AM Hindi Medium: (Delhi) - GS Foundation (P+M) : 6th July 2026, 6:00 PM Hindi Medium: (Prayagraj) - GS Foundation (P+M) : 5th July 2026, 8:00 AM English Medium: (Delhi) - GS Foundation (P+M) : 26th July 2026 English Medium: (Prayagraj) - GS Foundation (P+M) : 15th July 2026, 8:00 AM

GS Paper-3

India Approves First Dengue Vaccine (QDENGA): DCGI Clears TAK-003 for Individuals Aged 4–60 Years

20-Jul-2026

The Drug Controller General of India (DCGI) has granted market authorization to Takeda Biopharmaceuticals India's QDENGA (TAK-003), making it the first dengue vaccine approved in India.

What is ‘Boss Scam’? SEBI Warns Companies Against AI-Driven Executive Impersonation Fraud

20-Jul-2026

The Securities and Exchange Board of India (SEBI) has recently cautioned regulated entities and listed companies against an emerging cyber fraud known as the ‘Boss Scam’, where fraudsters impersonate Chief Executive Officers (CEOs), Managing Directors (MDs), and other senior executives to trick finance teams into transferring funds to fraudulent bank accounts.

Gujarat Tops NITI Aayog’s First Investment Friendliness Index 2026

20-Jul-2026

NITI Aayog has released the first-ever Investment Friendliness Index (IFI) 2026. Gujarat ranked first among 17 major States with a score of 56.6, followed by Maharashtra (53.7) and Tamil Nadu (53.3).

India Approves Novo Nordisk’s Wegovy for Fatty Liver Disease (MASH): Key Features, Benefits & Significance

18-Jul-2026

India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved Novo Nordisk's Wegovy (Semaglutide 2.4 mg injection) for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH), a serious form of fatty liver disease.

MH-60R Seahawk Helicopter: Features, India's Procurement, Strategic Importance & India-US Defence Partnership

18-Jul-2026

The Indian Navy has received another MH-60R Seahawk multi-role naval helicopter from the United States, which arrived at INS Garuda, Kochi.

Nasha Mukt Bharat Abhiyaan Reaches 29.32 Crore Citizens: India's Drug-Free Mission Gains Nationwide Momentum

18-Jul-2026

The Ministry of Social Justice and Empowerment has announced that the Nasha Mukt Bharat Abhiyaan (NMBA) has reached over 29.32 crore citizens across India through awareness campaigns and community participation.

Serum Institute Joins Global Race for First New TB Vaccine in a Century (M72/AS01E): Key Features, Clinical Trials, Significance

17-Jul-2026

The Serum Institute of India (SII) has entered into a strategic partnership with the Gates Medical Research Institute (Gates MRI) to manufacture M72/AS01E, a promising tuberculosis (TB) vaccine candidate currently undergoing Phase III clinical trials.

RBI's New Prudential Framework for Specified Non-Financial Assets (SNFAs): Key Features, Objectives & Significance

17-Jul-2026

The Reserve Bank of India (RBI) has introduced a comprehensive prudential framework for Specified Non-Financial Assets (SNFAs) through the Commercial Banks – Resolution of Stressed Assets Directions, 2025 (Third Amendment Directions, 2026).

Sub-Mission on Agricultural Mechanization (SMAM): Enhancing Productivity through Farm Mechanization

17-Jul-2026

The Sub-Mission on Agricultural Mechanization (SMAM) has significantly expanded access to farm machinery across India, especially for small and marginal farmers, women, SC/ST farmers, Farmer Producer Organizations (FPOs), and North-Eastern States.

India’s Bioeconomy to Reach $300 Billion by 2030; Government Launches BRCP Phase-III to Strengthen Biomedical Research

16-Jul-2026

The Government of India has launched Phase-III of the Biomedical Research Career Programme (BRCP) with an investment of ₹1,500 crore.

upsc english
« »
  • SUN
  • MON
  • TUE
  • WED
  • THU
  • FRI
  • SAT
Have any Query?

Our support team will be happy to assist you!

OR